Search research articles
Contact Us
Filters
Showing results (71-80 of 143) with videos related to
Page
of 15
Sort By:
Clinical Neuropharmacology
|
December 1, 1993
Sumatriptan does not affect vasopressin secretion in humans
T Barreca, R Franceschini, A Cataldi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1980
Evaluation of twenty-four-hour secretory patterns of growth hormone and insulin in patients with myotonic dystrophy
T Barreca, A Muratorio, A Sannia, et al.
Chronobiologia
|
January 1, 1980
The 24-h pattern of human prolactin and growth hormone in healthy elderly subjects
L Murri, T Barreca, G Cerone, et al.
Clinical Endocrinology
|
April 1, 1983
Nyctohemeral pattern of serum LH, FSH and PRL in patients with myotonic dystrophy
T Barreca, B Rossi, G Magnani, et al.
Acta Endocrinologica
|
November 1, 1983
Changes in pituitary secretion induced by an agonist-antagonist opioid drug, buprenorphine
E Rolandi, A Marabini, R Franceschini, et al.
British Journal of Clinical Pharmacology
|
August 1, 1984
Pituitary secretion after administration of a new cerebroactive drug, fipexide
E Rolandi, R Franceschini, A Marabini, et al.
European Neurology
|
January 1, 1980
Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea
L Murri, A Iudice, A Muratorio, et al.
Lancet (London, England)
|
October 5, 1974
Letter: Plasma-prolactin in breast cancer
E Rolandi, T Barreca, P Masturzo, et al.
La Nouvelle Presse Medicale
|
December 28, 1974
[Letter: Prolactin and breast cancer]
E Rolandi, T Barreca, P Masturzo, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study
E Rolandi, R Franceschini, A Cataldi, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 143) with videos related to
Sort By:
Page
of 15
Clinical Neuropharmacology
|
December 1, 1993
Sumatriptan does not affect vasopressin secretion in humans
T Barreca, R Franceschini, A Cataldi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1980
Evaluation of twenty-four-hour secretory patterns of growth hormone and insulin in patients with myotonic dystrophy
T Barreca, A Muratorio, A Sannia, et al.
Chronobiologia
|
January 1, 1980
The 24-h pattern of human prolactin and growth hormone in healthy elderly subjects
L Murri, T Barreca, G Cerone, et al.
Clinical Endocrinology
|
April 1, 1983
Nyctohemeral pattern of serum LH, FSH and PRL in patients with myotonic dystrophy
T Barreca, B Rossi, G Magnani, et al.
Acta Endocrinologica
|
November 1, 1983
Changes in pituitary secretion induced by an agonist-antagonist opioid drug, buprenorphine
E Rolandi, A Marabini, R Franceschini, et al.
British Journal of Clinical Pharmacology
|
August 1, 1984
Pituitary secretion after administration of a new cerebroactive drug, fipexide
E Rolandi, R Franceschini, A Marabini, et al.
European Neurology
|
January 1, 1980
Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea
L Murri, A Iudice, A Muratorio, et al.
Lancet (London, England)
|
October 5, 1974
Letter: Plasma-prolactin in breast cancer
E Rolandi, T Barreca, P Masturzo, et al.
La Nouvelle Presse Medicale
|
December 28, 1974
[Letter: Prolactin and breast cancer]
E Rolandi, T Barreca, P Masturzo, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study
E Rolandi, R Franceschini, A Cataldi, et al.
Page
of 15